Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
Clinical trial NCT04396860 · COMPLETED
Trial details
- NCT number
- NCT04396860
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2023-01-13
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.